AMLN Amylin Pharmaceuticals, Inc. (MM)

/C O R R E C T I O N -- Amylin Pharmaceuticals, Inc./ In the news release, Amylin Pharmaceuticals (NASDAQ:AMLN) to Present at Goldman Sachs Therapeutic Conference, issued earlier today by Amylin Pharmaceuticals, Inc. over PR Newswire, we are advised by the company that the first paragraph, first sentence, should read "Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the Goldman Sachs Therapeutic Conference on Wednesday, September 8, 2004 at 2:00 p.m. GMT (6:00 a.m. PT) in London, England," rather than "(6:00 a.m. ET)," as originally issued inadvertently. PRNewswire -- Sept. 3 DATASOURCE: Amylin Pharmaceuticals, Inc. Web site: http://www.amylin.com/

Copyright